Most Patients With Neovascular Eye Disease Prefer Anti-VEGF Implant

(MedPage Today) -- Reduced treatment burden for neovascular age-related macular degeneration met with overwhelming approval in an analysis of patient-reported outcomes (PROs) from a randomized trial. After 40 weeks of follow-up, about two-thirds...
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news